α-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and β cell dysfunction

European Journal of Clinical Investigation

Volumn 42, Issue 6, 2012, Pages 637-648

  Tian, Yu Feng ^a,b   Hsieh, Chang Hsun ^c   Hsieh, Yen Ju ^d   Chen, Yu Ting ^d   Peng, Yi Jen ^c   Hsieh, Po Shiuan ^c,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Lipoic acid; Beta cell dysfunction; Chronic hepatic inflammation; Oxidative stress; Portal endotoxaemia

Indexed keywords

AMYLASE; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; DRUG-INDUCED LIVER INJURY; ENDOTOXEMIA; INSULIN-SECRETING CELLS; LIVER; MALE; OXIDATIVE STRESS; PANCREAS; PORTAL SYSTEM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID;

EID: 84860917437     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02630.x     Document Type: Article

References (33)

1. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007;47:571-9.
2. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. [see comment]. Gut 2001;48:206-11.
3. Iimuro Y, Frankenberg MV, Arteel GE, Bradford BU, Wall CA, Thurman RG. Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males. Am J Physiol 1997;272:G1186-94.
4. Hwang SJ, Chen LK. Chronic hepatitis C and diabetes mellitus. J Chin Med Assoc 2006;69:143-5.
5. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009;15:280-8.
6. Brischetto R, Corno C, Amore MG, Leotta S, Pavone S, Bonsignore L et al. Prevalence and significance of type-2 diabetes mellitus in chronic liver disease, correlated with hepatitis C virus. Ann Ital Med Int 2003;18:31-6.
7. Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H et al. Exocrine pancreatic function in chronic liver diseases. Am J Gastroenterol 1991;86:201-4.
8. Hsieh PS, Chan JY, Shyu JF, Chen YT, Loh CH, Chan JYH. Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic beta-cell dysfunction in rats. Eur J Clin Invest 2008;38:640-8.
9. Hsieh P-S. Inflammatory change of fatty liver induced by intraportal low-dose lipopolysaccharide infusion deteriorates pancreatic insulin secretion in fructose-induced insulin-resistant rats. Liver Int 2008;28:1167-75.
10. Foo NP, Lin SH, Lee YH, Wu MJ, Wang YJ. Alpha-lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-beta. Toxicology 2011;282:39-46.
11. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM, Shay KP et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009;1790:1149-60.
12. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002;17:677-81.
13. Deschenes M, Somberg KA. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus. Am J Gastroenterol 1998;93:483.
14. Cremer DR, Rabeler R, Roberts A, Lynch B. Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol 2006;46:29-41.
15. Hsieh PS, Tsai HC, Kuo CH, Chan JY, Shyu JF, Cheng WT et al. Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats. Eur J Clin Invest 2008;38:812-9.
16. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. [see comment]. Am J Physiol 1979;237:E214-23.
17. Grodsky GM. A new phase of insulin secretion. How will it contribute to our understanding of beta-cell function? Diabetes 1989;38:673-8.
18. Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 2004;287:E371-85.
19. Lira FS, Rosa JC, Pimentel GD, Souza HA, Caperuto EC, Carnevali LC Jr et al. Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects. Lipids Health Dis 2010;9:82.
20. Togashi N, Ura N, Higashiura K, Murakami H, Shimamoto K. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000;18:1605-10.
21. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 2009;47:1176-83.
22. Sowell MO, Mukhopadhyay N, Cavazzoni P, Shankar S, Steinberg HO, Breier A et al. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. J Clin Endocrinol Metab 2002;87:2918-23.
23. Lykkesfeldt J, Hagen TM, Vinarsky V, Ames BN. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes - reversal with (R)-alpha-lipoic acid supplementation. FASEB J 1998;12:1183-9.
24. Abdin AA, El-Hamid MA, El-Seoud SH, Balaha MF. Effect of pentoxifylline and/or alpha lipoic acid on experimentally induced acute pancreatitis. Eur J Pharmacol 2010;643:289-96.
25. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998;24:1023-39.
26. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996;20:463-6.
27. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-8.
28. Ho E, Bray TM. Antioxidants, NF{kappa}B activation, and diabetogenesis. Proc Soc Exp Biol Med 1999;222:205-13.
29. Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 2004;1011:168-76.
30. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-51.
31. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 2010;48:1121-32.
32. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005;11:183-90.
33. Stein LL, Dong MH, Loomba R. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. Adv Ther 2009;26:893-907.